Major Quality Recovery for Humana Medicare Advantage Plans
Humana announced a major turnaround in its government quality performance: 95% of its Medicare Advantage members will be enrolled in plans rated four stars or higher in 2027.
This represents a massive jump from 2026, when only 20% of Humana’s Medicare Advantage members were enrolled in highly rated plans. The recovery follows two difficult rating cycles, including a sharp decline in its 2025 ratings that led to an unsuccessful lawsuit in October 2025 challenging the methodology used by federal health officials.
Financial Impact and Government Bonus Payments
Medicare Advantage star ratings carry substantial financial weight for health plans serving adults aged 65 and older and individuals with disabilities. Higher ratings make plans eligible for significant federal bonus payments.
- $4.8 Billion Bonus Potential: Evercore ISI estimates that Humana’s improved ratings across health-plan quality, drug-plan quality, and hospital readmission measures could yield $4.8 billion in bonus payments in 2028.
- Earnings Outlook: Analysts at Baird note that the true impact on profitability will depend on how much additional funding Humana reinvests into member benefits and healthcare provider arrangements versus allocating to bottom-line earnings.
Humana vs. Industry Competitors in 2027
Humana’s projected enrollment in top-rated plans significantly outpaces both industry averages and major competitors:
| Health Plan Provider | 2026 High-Rated Enrollment (4+ Stars) | 2027 Projected High-Rated Enrollment (4+ Stars) |
|---|---|---|
| Humana | 20% | 95% |
| UnitedHealth | 81% | ~67% |
| CVS Health | 84% | ~70% |
| Industry Average | — | ~71% |
Estimates according to J.P. Morgan and the US Health Department.
